| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 12/11/2013 | CN103432070A 左乙拉西坦注射液和制法 Levetiracetam injection and production method |
| 12/11/2013 | CN103432068A Pridinol mesylate injection and preparation method thereof |
| 12/11/2013 | CN102949339B Rocuronium bromide-containing injection |
| 12/11/2013 | CN102600316B Chinese medicinal herb preparation for treating closed injury and preparation method thereof |
| 12/10/2013 | US8603486 Protein A compositions and methods of use |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/05/2013 | WO2013181084A1 Antispasmodic 1,2-diols and 1,2,3-triols |
| 12/05/2013 | WO2013180271A1 Prodrug of fluorine-containing amino acid |
| 12/05/2013 | CA2875080A1 Prodrug of fluorine-containing amino acid |
| 12/05/2013 | CA2874961A1 Antispasmodic 1,2-diols and 1,2,3-triols |
| 12/04/2013 | CN103417913A TCM ointment for treatment of lumbar disc herniation and preparation method thereof |
| 12/04/2013 | CN103417887A Chinese medicine for treating chronic soft tissue injury, and preparation method thereof |
| 12/04/2013 | CN103417880A TCM composition and preparation method thereof |
| 12/04/2013 | CN103417631A Traditional Chinese medicine for treating lumbar disc herniation |
| 12/04/2013 | CN103416312A Plants as functional siRNA vehicles and preparation methods and uses thereof |
| 12/04/2013 | CN103416311A Plants as functional microRNA vehicles and preparation methods and uses thereof |
| 12/04/2013 | CN102805841B Medicament for treating adverse reaction caused by anesthetics |
| 12/04/2013 | CN102631644B External-use traditional Chinese medicine for treating myositis ossificans |
| 12/04/2013 | CN102462672B Ramosetron transdermal patch and preparation method thereof |
| 12/04/2013 | CN102424818B Caspase-1-ES cell line induced by mifepristone |
| 11/28/2013 | WO2013177458A1 Compositions for increasing strength, muscle mass, and lean body mass |
| 11/28/2013 | WO2013177428A1 Methods for increasing muscle contractility |
| 11/28/2013 | WO2013177176A1 Compositions and methods for inducing myoblast differentiation and myotube formation |
| 11/28/2013 | WO2013175386A1 Compositions and methods for increasing strength and muscle mass |
| 11/28/2013 | WO2013175266A1 Method for increasing muscle mass and strength |
| 11/27/2013 | EP2666777A1 Certain chemical entities having an imidazo<4,5-b>pyrazin-2(3H)-one core, compositions and methods |
| 11/27/2013 | CN103408501A Benzyl pyrimidine derivatives, and preparation method and medical application thereof |
| 11/27/2013 | CN103405774A Novel drug targeting delivery adjuvant |
| 11/27/2013 | CN103405751A Composition with cell repairing function and preparation method and application thereof |
| 11/27/2013 | CN103405740A Chinese medicine composition for external use and preparation method thereof |
| 11/27/2013 | CN103405733A Chinese medicine preparation for treating joint pain of middle aged and elderly people |
| 11/27/2013 | CN102579978B External traditional Chinese medicine composition for treating scapulohumeral periarthritis |
| 11/26/2013 | US8591950 Hydrogel implants with varying degrees of crosslinking |
| 11/21/2013 | WO2013173506A2 Method of treating muscular degradation |
| 11/21/2013 | WO2013172681A1 Use of kaempferia parviflora wall. ex. baker extracts or flavone compound for preventing or treating muscle diseases, or improving muscle function |
| 11/21/2013 | WO2013170970A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and an oxicam |
| 11/21/2013 | WO2013170385A1 Oligonucleotide chelate complex methods |
| 11/21/2013 | US20130310388 Modulators of TNF-Alpha Signaling |
| 11/21/2013 | US20130309215 Pharmaceutical composition |
| 11/20/2013 | EP2663576A2 Novel wnt compositions and therapeutic uses of such compositions |
| 11/20/2013 | EP1567022B1 Sustained improver of muscular fatigue |
| 11/20/2013 | CN103396485A Method and composition for targeting polyubiquitin |
| 11/20/2013 | CN103393950A Tradtional Chinese medicine composition for treating bone fracture and preparation method thereof |
| 11/20/2013 | CN103393862A Chinese medicinal composition for treating lumbocrural pain |
| 11/20/2013 | CN103393854A Plant essential oil for miraculous moxibustion as well as preparation method and application |
| 11/20/2013 | CN102698200B Chinese medicinal composition for treating strain and sprain and preparation method thereof |
| 11/19/2013 | US8586775 Therapeutic compounds and methods of use |
| 11/19/2013 | US8586317 Methods of diagnosing hypophosphatemic disorders |
| 11/19/2013 | CA2611140C Compositions and methods for enhancing nitric oxide delivery |
| 11/19/2013 | CA2603030C Benzyloxypropylamine derivative |
| 11/14/2013 | WO2013170189A1 Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow |
| 11/14/2013 | WO2013166557A1 Methods for treating cachexia |
| 11/14/2013 | WO2012136385A8 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivative and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation |
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/14/2013 | US20130302889 Differentiation of Bone Marrow Cells into Neuronal Cells and Uses Therefor |
| 11/13/2013 | EP2661266A2 Chemosensory receptor ligand-based therapies |
| 11/13/2013 | CN103387580A Stemona root alkaloid monomer components and applications thereof |
| 11/13/2013 | CN103386057A Preparation method and application of stemona effective part extract |
| 11/13/2013 | CN103386045A Radix stephaniae tetrandrae-semen coicis-fructus forsythiae pills as well as preparation method and quality standard detection method thereof |
| 11/13/2013 | CN103385944A Formula for osteoproliferation and application method thereof |
| 11/13/2013 | CN103385941A Chinese herbal medicine pain-relieving medicinal moxibustion |
| 11/13/2013 | CN103385940A Traditional Chinese medicine percolate for reducing lower limb muscle tension of spastic cerebral palsy |
| 11/13/2013 | CN102871981B Tablet medicine compound containing levetiracetam |
| 11/13/2013 | CN102105144B Sphingosine 1 phosphate receptor modulators and use thereof to treat muscle inflammation |
| 11/13/2013 | CN102090560B Synergism of GOS and polyfructose |
| 11/13/2013 | CN102076344B Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 11/12/2013 | US8580743 Modified galectin 9 proteins and methods of treatment using them |
| 11/12/2013 | US8580563 Placental stem cells |
| 11/12/2013 | CA2714357C Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 11/07/2013 | US20130295128 Chimeric vaccines |
| 11/06/2013 | EP2658535A1 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate |
| 11/06/2013 | EP2658533A2 Combination of components for the prevention and treatment of frailty |
| 11/06/2013 | CN103384520A Combination of components for the prevention and treatment of frailty |
| 11/06/2013 | CN103381216A Traditional Chinese medicine composite for curing periarthritis of shoulder and preparation method thereof |
| 11/06/2013 | CN103381150A Pharmaceutical composition and application thereof |
| 11/06/2013 | CN102743707B Pill for treating acute lumbar sprain |
| 11/06/2013 | CN101909651B External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 11/06/2013 | CN101679523B Novel fully human anti-vap-1 monoclonal antibodies |
| 11/05/2013 | US8575204 Nicotinamide derivates useful as P38 inhibitors |
| 11/05/2013 | US8575138 Method for providing neuroprotection |
| 11/05/2013 | CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses |
| 10/31/2013 | WO2004061073A9 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 10/31/2013 | WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis |
| 10/31/2013 | US20130287762 Neutralizing antibodies against gdf-8 and uses therefor |
| 10/31/2013 | US20130287725 Biocompatible polymers, process for their preparation and compositions containing them |
| 10/30/2013 | EP2656845A1 Composition for modulating stem cell growth with prostaglandins |
| 10/30/2013 | CN103373959A Preparation method of cis-benzyl isoquinoline compound and application thereof |
| 10/30/2013 | CN103372023A Application of chitosan oligosaccharide in preparation of medicaments for preventing and/or treating neurodegenerative diseases |
| 10/30/2013 | CN102558276B Non-sizing pipecuronium and preparation method and purpose thereof |
| 10/30/2013 | CN102239164B 2H-chromene compound and derivative thereof |
| 10/30/2013 | CN102219837B Recombinant full-length A-type botulinum toxin mutant vaccine |
| 10/30/2013 | CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases |
| 10/29/2013 | US8569543 CCR9 inhibitors and methods of use thereof |
| 10/24/2013 | US20130281418 Use of hydroxypregnenolone derivatives for enhancing health and physical performance |
| 10/24/2013 | US20130281416 Pharmaceutical composition |
| 10/24/2013 | US20130280354 Composition and Method for Using Sage |
| 10/23/2013 | EP2653157A1 Astaxanthin for improving muscle atrophy |
| 10/23/2013 | EP2651221A1 Methods of producing and using brassinosteroids to promote growth, repair and maintenance of skeletal muscle and skin |
| 10/23/2013 | CN103370289A 4-hydroxybutyric acid deuterated analogs |